Synapse

← Orphan Drugs Research and Reviews

Papers in Orphan Drugs Research and Reviews

Page 1 · newest first

  1. Spotlight on anagrelide hydrochloride for the treatment of essential thrombocythemiaOrphan Drugs Research and Reviews · 2017
  2. Nitisinone: a reviewOrphan Drugs Research and Reviews · 2017
  3. Pompe disease: clinical perspectivesOrphan Drugs Research and Reviews · 2016
  4. Adverse events reported for hereditary angioedema medications: a retrospective study of spontaneous reports submitted to the EudraVigilance database, 2007-2013Orphan Drugs Research and Reviews · 2016
  5. Orphan drugs for sickle vaso-occlusion: dawn of a new era of targeted treatmentOrphan Drugs Research and Reviews · 2015
  6. Denosumab in the treatment of hypercalcemia secondary to malignancyOrphan Drugs Research and Reviews · 2015
  7. Orphan drugs in development for primary biliary cirrhosis: challenges and progressOrphan Drugs Research and Reviews · 2015
  8. Paroxysmal nocturnal hemoglobinuria: new concepts in pathophysiology and treatmentOrphan Drugs Research and Reviews · 2015
  9. The efficacy and safety of adalimumab in ocular inflammatory diseaseOrphan Drugs Research and Reviews · 2015
  10. Drugs in development and dietary approach for Duchenne muscular dystrophyOrphan Drugs Research and Reviews · 2015
  11. Fahr's disease: current perspectivesOrphan Drugs Research and Reviews · 2015
  12. Amyotrophic lateral sclerosis: clinical perspectivesOrphan Drugs Research and Reviews · 2015
  13. Update on the challenges of treating trigeminal neuralgiaOrphan Drugs Research and Reviews · 2015
  14. Orphan drugs in development for long-chain fatty acid oxidation disorders: challenges and progressOrphan Drugs Research and Reviews · 2015
  15. Optimal management of interstitial lung disease associated with dermatomyositis/polymyositis: lessons from the Japanese experienceOrphan Drugs Research and Reviews · 2014
  16. New treatments in development for Pseudomonas aeruginosa infections in the lungs of individuals with cystic fibrosisOrphan Drugs Research and Reviews · 2014
  17. Orphan drugs in development for urea cycle disorders: current perspectivesOrphan Drugs Research and Reviews · 2014
  18. An update on gene therapy for the treatment of lipoprotein lipase deficiencyOrphan Drugs Research and Reviews · 2014
  19. Stiripentol for the treatment of Dravet syndromeOrphan Drugs Research and Reviews · 2014
  20. Access to cross-border health care services for patients with rare diseases in the European UnionOrphan Drugs Research and Reviews · 2014
  21. A 30-year retrospective: National Organization for Rare Disorders, the Orphan Drug Act, and the role of rare disease patient advocacy groupsOrphan Drugs Research and Reviews · 2014
  22. Profile of aminopyridines for Lambert–Eaton myasthenic syndromeOrphan Drugs Research and Reviews · 2014
  23. Do ultra-orphan medicinal products warrant ultra-high prices? A reviewOrphan Drugs Research and Reviews · 2013
  24. Tipifarnib and farnesyltransferase inhibitors in the treatment of inflammatory breast cancer: is the story over? A reviewOrphan Drugs Research and Reviews · 2013
  25. Current management options for tyrosinemiaOrphan Drugs Research and Reviews · 2013
  26. Wilson’s disease: a review of treatment options with a focus on zinc therapyOrphan Drugs Research and Reviews · 2012
  27. Betaine treatment of cystathionine β-synthase-deficient homocystinuria; does it work and can it be improved?Orphan Drugs Research and Reviews · 2012
  28. Prussian blue as an antidote for radioactive thallium and cesium poisoningOrphan Drugs Research and Reviews · 2012
  29. Potential role of enzastaurin in the treatment of patients with relapsed or refractory advanced cutaneous T-cell lymphomas: a reviewOrphan Drugs Research and Reviews · 2012